Epstein-Barr Virus Nuclear Antigen Leader Protein Coactivates EP300

Journal of Virology
Chong WangBo Zhao

Abstract

Epstein-Barr virus nuclear antigen (EBNA) leader protein (EBNALP) is one of the first viral genes expressed upon B-cell infection. EBNALP is essential for EBV-mediated B-cell immortalization. EBNALP is thought to function primarily by coactivating EBNA2-mediated transcription. Chromatin immune precipitation followed by deep sequencing (ChIP-seq) studies highlight that EBNALP frequently cooccupies DNA sites with host cell transcription factors (TFs), in particular, EP300, implicating a broader role in transcription regulation. In this study, we investigated the mechanisms of EBNALP transcription coactivation through EP300. EBNALP greatly enhanced EP300 transcription activation when EP300 was tethered to a promoter. EBNALP coimmunoprecipitated endogenous EP300 from lymphoblastoid cell lines (LCLs). EBNALP W repeat serine residues 34, 36, and 63 were required for EP300 association and coactivation. Deletion of the EP300 histone acetyltransferase (HAT) domain greatly reduced EBNALP coactivation and abolished the EBNALP association. An EP300 bromodomain inhibitor also abolished EBNALP coactivation and blocked the EP300 association with EBNALP. EBNALP sites cooccupied by EP300 had significantly higher ChIP-seq signals for sequence-sp...Continue Reading

References

Dec 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·J I CohenE Kieff
Jul 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J SampleE Kieff
Aug 2, 1994·Proceedings of the National Academy of Sciences of the United States of America·S R GrossmanE Kieff
Jan 5, 2000·Proceedings of the National Academy of Sciences of the United States of America·L WangE Kieff
Jun 14, 2000·Journal of Virology·Y C PengE J Androphy
Oct 12, 2000·Molecular and Cellular Biology·M LiJ U Jung
Feb 13, 2001·Journal of Virology·I HanE Kieff
Mar 30, 2001·The Journal of Biological Chemistry·R H SeeY Shi
Mar 30, 2001·The Journal of Biological Chemistry·N Vo, R H Goodman
Apr 30, 2003·Molecular Cell·David GirdwoodRonald T Hay
Jan 21, 2004·Proceedings of the National Academy of Sciences of the United States of America·Chih-Wen PengShizuko Harada
Feb 18, 2004·Oncogene·Cristiano SimonePier Lorenzo Puri
Mar 30, 2004·Journal of Virology·Alexey V GordadzePaul D Ling
Sep 29, 2004·Journal of Virology·Chih-Wen PengElliott Kieff
Jun 14, 2005·The Journal of Biological Chemistry·Maofu FuRichard G Pestell
Sep 24, 2005·The EMBO Journal·Paul D LingDonald B Bloch
Feb 1, 2006·Proceedings of the National Academy of Sciences of the United States of America·Bo ZhaoEllen Cahir-McFarland
Dec 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·D PortalE Kieff
Mar 8, 2007·Blood·Chih-Wen PengElliott Kieff
Feb 6, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Aitor G GranjaYolanda Revilla
Apr 27, 2011·Proceedings of the National Academy of Sciences of the United States of America·Daniel PortalElliott Kieff
Jul 13, 2011·Proceedings of the National Academy of Sciences of the United States of America·Bo ZhaoElliott Kieff
Nov 4, 2011·Science Translational Medicine·Jeffrey I CohenGary J Nabel
Sep 8, 2012·Genome Research·Stephen G LandtMichael Snyder
Oct 30, 2013·Proceedings of the National Academy of Sciences of the United States of America·Daniel PortalElliott Kieff
Jun 20, 2014·Journal of the American Chemical Society·Duncan A HayPaul E Brennan
Aug 28, 2014·Cell Reports·Bo ZhaoBenjamin E Gewurz

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

HIV/AIDS-Related Malignancies

HIV/AIDS infection increases the risk of non-communicable diseases common in the aged including HIV/AIDS-related malignancies. Discover the latest research in HIV/AIDS-related malignancies.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

CRISPR in Cancer

CRISPR-Cas system enables the editing of genes to create or correct mutations. Given that genome instability and mutation is one of the hallmarks of cancer, the CRISPR-Cas system is being explored to genetically alter and eliminate cancer cells. Here is the latest research.

B cells: Gene Expression

B lymphocytes are white blood cells that play a role in the adaptive immune system by secreting antibodies. Here is the latest research on gene expression in B cells.

Virology & CRISPR

This feed focuses on the virology of CRISPR and its use in developing CRISPR-Cas systems. Discover the latest research here.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.